Madrigal Pharmaceuticals, Inc. MDGL
399.63 USD -0.47 (-0.12%)
At closeNov 6, 2026, 4:02 PM EST
399.93 +0.30 +0.08%
After hours · Nov 6, 4:02 PM ET
378.28 Day range 401.61
353.54 52-week range 615.00
- YTD
- -31.38%
- 1 year
- -18.21%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 958.40M | 180.13M | 0 | 0 | 0 | |
| 902.25M | 173.90M | 0 | 0 | 0 | |
| -300.10M | -497.88M | -380.50M | -293.57M | -242.48M | |
| -288.28M | -465.89M | -373.63M | -295.35M | -241.85M | |
| -12.85 | -21.90 | -19.99 | -17.23 | -14.63 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 203.78M | 105.02M | 99.92M | 331.55M | 36.27M | |
| 1.26B | 1.04B | 640.55M | 362.57M | 273.33M | |
| 656.90M | 287.86M | 235.21M | 165.18M | 77.22M | |
| 347.63M | 119.57M | 117.19M | 49.89M | 797.00K | |
| 602.69M | 754.38M | 405.33M | 197.39M | 196.11M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -189.55M | -455.57M | -324.23M | -224.86M | -183.92M | |
| 32.32M | -274.39M | -502.52M | 206.69M | -5.05M | |
| 255.98M | 735.06M | 595.12M | 313.45M | 171.24M | |
| -3.47M | -6.46M | -1.48M | -217.00K | -209.00K | |
| 98.76M | 5.10M | -231.63M | 295.28M | -17.73M |